Your browser doesn't support javascript.
loading
Blood-based T cell receptor anti-viral CDR3s are associated with worse overall survival for neuroblastoma.
Kacsoh, Dorottya B; Diaz, Michael J; Gozlan, Etienne C; Sahoo, Arpan; Song, Joanna J; Yeagley, Michelle; Chobrutskiy, Andrea; Chobrutskiy, Boris I; Blanck, George.
Afiliação
  • Kacsoh DB; College of Medicine, University of Central Florida, Orlando, FL, 32827, USA.
  • Diaz MJ; Department of Molecular Medicine, Morsani College of Medicine, University of South Florida, 12901 Bruce B. Downs Bd. MDC7, Tampa, FL, 33612, USA.
  • Gozlan EC; Department of Molecular Medicine, Morsani College of Medicine, University of South Florida, 12901 Bruce B. Downs Bd. MDC7, Tampa, FL, 33612, USA.
  • Sahoo A; Department of Molecular Medicine, Morsani College of Medicine, University of South Florida, 12901 Bruce B. Downs Bd. MDC7, Tampa, FL, 33612, USA.
  • Song JJ; Department of Molecular Medicine, Morsani College of Medicine, University of South Florida, 12901 Bruce B. Downs Bd. MDC7, Tampa, FL, 33612, USA.
  • Yeagley M; University of Pittsburgh Medical Center, Pittsburgh, PA, 15261, USA.
  • Chobrutskiy A; Department of Pediatrics, Oregon Health and Science University, Portland, OR, 97239, USA.
  • Chobrutskiy BI; Department of Internal Medicine, Oregon Health and Science University Hospital, Portland, OR, 97239, USA.
  • Blanck G; Department of Molecular Medicine, Morsani College of Medicine, University of South Florida, 12901 Bruce B. Downs Bd. MDC7, Tampa, FL, 33612, USA. gblanck@usf.edu.
J Cancer Res Clin Oncol ; 149(13): 12047-12056, 2023 Oct.
Article em En | MEDLINE | ID: mdl-37421457

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Antivirais / Neuroblastoma Tipo de estudo: Risk_factors_studies Limite: Humans Idioma: En Revista: J Cancer Res Clin Oncol Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Antivirais / Neuroblastoma Tipo de estudo: Risk_factors_studies Limite: Humans Idioma: En Revista: J Cancer Res Clin Oncol Ano de publicação: 2023 Tipo de documento: Article